All Recalls

95,018 total recalls in our database

Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.

Aug 3, 2023 Prescription Drugs Nationwide View Details โ†’

Users were reporting that the device was not charging as expected. It was discovered that users were unaware that the Cardiosave console was not completely inserted into the hospital cart. If the console is not fully inserted back into the cart the battery(ies) will not charge.

Jul 31, 2023 Infusion Pumps Nationwide View Details โ†’

Epoxy used during manufacturing of the LifeSPARC Pump may have uncured epoxy. if undetectable curing may result in added risk of early pump failure,

Jun 30, 2023 Infusion Pumps Nationwide View Details โ†’

Users were reporting instances of "Gas Loss in IAB Circuit" and "Gas Gain in IAB Circuit" alarms while providing therapy. An internal investigation of the complaints determined that there is a potential trigger for these alarms that was not listed in the IFU: Patient Movement (coughing, general movement, and swallowing). Blood in the circuit, kins and abrasions of the tubing/catheter and certain patient conditions could also trigger these alarms. The HHE also identified hardware issues related to these alarms.

Jul 31, 2023 Infusion Pumps Nationwide View Details โ†’

Reagent Carryover from LDL Cholesterol Direct (DLDL), Total Protein II (TP), Triglycerides (Trig), and Triglycerides_2 (Trig_2) Impacting Magnesium (Mg) Results

Jan 27, 2023 Diagnostic Equipment Nationwide View Details โ†’

Potential for reagent carryover on the Atellica CH 930 resulting in a positive bias that could impact quality control (QC), patient samples, and calibrator results with from AtellicaยฟCH Total Bilirubin_2 (TBil_2), Atellicaยฟ CH LDL Cholesterol (LDLC), Atellicaยฟ CH Gamma-Glutamyl Transferase (GGT) and Atellicaยฟ CH HDL Cholesterol (HDLC)

Jul 10, 2023 Diagnostic Equipment Nationwide View Details โ†’

Potential for reagent carryover on the Atellica CH 930 resulting in a positive bias that could impact quality control (QC), patient samples, and calibrator results with from Atellicaยฟ CH Total Bilirubin_2 (TBil_2), Atellicaยฟ CH LDL Cholesterol (LDLC), Atellicaยฟ CH Gamma-Glutamyl Transferase (GGT) and Atellica CH HDL Cholesterol (HDLC)

Jul 10, 2023 Diagnostic Equipment Nationwide View Details โ†’

Reagent Carryover from LDL Cholesterol Direct (DLDL), Total Protein II (TP), Triglycerides (Trig), and Triglycerides_2 (Trig_2) Impacting Magnesium (Mg) Results

Jan 27, 2023 Diagnostic Equipment Nationwide View Details โ†’